nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—PLA2G4A—Orlistat—obesity	0.49	1	CbGbCtD
Epirubicin—CHD1—hindbrain—obesity	0.00646	0.0756	CbGeAlD
Epirubicin—CHD1—respiratory system—obesity	0.00395	0.0461	CbGeAlD
Epirubicin—CHD1—adrenal cortex—obesity	0.00331	0.0387	CbGeAlD
Epirubicin—DHCR7—islet of Langerhans—obesity	0.00282	0.033	CbGeAlD
Epirubicin—CHD1—pituitary gland—obesity	0.00268	0.0313	CbGeAlD
Epirubicin—CHD1—adipose tissue—obesity	0.00267	0.0312	CbGeAlD
Epirubicin—YWHAG—islet of Langerhans—obesity	0.00259	0.0302	CbGeAlD
Epirubicin—YWHAG—respiratory system—obesity	0.00244	0.0285	CbGeAlD
Epirubicin—CHD1—adrenal gland—obesity	0.00239	0.028	CbGeAlD
Epirubicin—DHCR7—adrenal cortex—obesity	0.00223	0.0261	CbGeAlD
Epirubicin—AURKA—pituitary gland—obesity	0.00216	0.0252	CbGeAlD
Epirubicin—CHD1—endocrine gland—obesity	0.00207	0.0242	CbGeAlD
Epirubicin—YWHAG—adrenal cortex—obesity	0.00205	0.024	CbGeAlD
Epirubicin—AURKA—digestive system—obesity	0.00202	0.0236	CbGeAlD
Epirubicin—AURKA—adrenal gland—obesity	0.00193	0.0225	CbGeAlD
Epirubicin—YWHAG—cardiovascular system—obesity	0.00187	0.0219	CbGeAlD
Epirubicin—CHD1—liver—obesity	0.00187	0.0219	CbGeAlD
Epirubicin—PLA2G4A—respiratory system—obesity	0.00182	0.0213	CbGeAlD
Epirubicin—DHCR7—pituitary gland—obesity	0.0018	0.0211	CbGeAlD
Epirubicin—DHCR7—adipose tissue—obesity	0.0018	0.021	CbGeAlD
Epirubicin—DHCR7—digestive system—obesity	0.00169	0.0198	CbGeAlD
Epirubicin—AURKA—endocrine gland—obesity	0.00167	0.0195	CbGeAlD
Epirubicin—YWHAG—pituitary gland—obesity	0.00166	0.0194	CbGeAlD
Epirubicin—YWHAG—adipose tissue—obesity	0.00165	0.0193	CbGeAlD
Epirubicin—DHCR7—adrenal gland—obesity	0.00161	0.0188	CbGeAlD
Epirubicin—YWHAG—digestive system—obesity	0.00155	0.0182	CbGeAlD
Epirubicin—Doxorubicin—NOS1—obesity	0.00155	0.328	CrCbGaD
Epirubicin—PLA2G4A—adrenal cortex—obesity	0.00153	0.0179	CbGeAlD
Epirubicin—AURKA—liver—obesity	0.00151	0.0176	CbGeAlD
Epirubicin—YWHAG—adrenal gland—obesity	0.00148	0.0173	CbGeAlD
Epirubicin—UGT2B7—digestive system—obesity	0.0014	0.0164	CbGeAlD
Epirubicin—DHCR7—endocrine gland—obesity	0.0014	0.0163	CbGeAlD
Epirubicin—PLA2G4A—cardiovascular system—obesity	0.00139	0.0163	CbGeAlD
Epirubicin—Doxorubicin—AKR1C3—obesity	0.00133	0.282	CrCbGaD
Epirubicin—YWHAG—endocrine gland—obesity	0.00128	0.015	CbGeAlD
Epirubicin—DHCR7—liver—obesity	0.00126	0.0147	CbGeAlD
Epirubicin—PLA2G4A—pituitary gland—obesity	0.00124	0.0144	CbGeAlD
Epirubicin—PLA2G4A—adipose tissue—obesity	0.00123	0.0144	CbGeAlD
Epirubicin—TOP2A—adipose tissue—obesity	0.00117	0.0137	CbGeAlD
Epirubicin—UGT2B7—endocrine gland—obesity	0.00116	0.0135	CbGeAlD
Epirubicin—YWHAG—liver—obesity	0.00116	0.0135	CbGeAlD
Epirubicin—PLA2G4A—adrenal gland—obesity	0.0011	0.0129	CbGeAlD
Epirubicin—TOP2A—adrenal gland—obesity	0.00105	0.0123	CbGeAlD
Epirubicin—UGT2B7—liver—obesity	0.00104	0.0122	CbGeAlD
Epirubicin—Doxorubicin—NQO1—obesity	0.001	0.211	CrCbGaD
Epirubicin—PLA2G4A—endocrine gland—obesity	0.000957	0.0112	CbGeAlD
Epirubicin—ABCC1—adrenal cortex—obesity	0.000874	0.0102	CbGeAlD
Epirubicin—Doxorubicin—NOS3—obesity	0.000844	0.178	CrCbGaD
Epirubicin—ABCC1—pituitary gland—obesity	0.000706	0.00826	CbGeAlD
Epirubicin—ABCC1—adipose tissue—obesity	0.000704	0.00823	CbGeAlD
Epirubicin—ABCC1—adrenal gland—obesity	0.000631	0.00738	CbGeAlD
Epirubicin—ABCC1—liver—obesity	0.000493	0.00577	CbGeAlD
Epirubicin—Orthostatic hypotension—Topiramate—obesity	0.00013	0.000519	CcSEcCtD
Epirubicin—Discomfort—Sibutramine—obesity	0.00013	0.000518	CcSEcCtD
Epirubicin—Hypokalaemia—Topiramate—obesity	0.00013	0.000517	CcSEcCtD
Epirubicin—Muscle spasms—Bupropion—obesity	0.00013	0.000516	CcSEcCtD
Epirubicin—Infection—Orlistat—obesity	0.00013	0.000516	CcSEcCtD
Epirubicin—Breast disorder—Topiramate—obesity	0.000129	0.000513	CcSEcCtD
Epirubicin—Dry mouth—Sibutramine—obesity	0.000129	0.000513	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Topiramate—obesity	0.000128	0.000512	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Topiramate—obesity	0.000128	0.000512	CcSEcCtD
Epirubicin—Nervous system disorder—Orlistat—obesity	0.000128	0.00051	CcSEcCtD
Epirubicin—Nasopharyngitis—Topiramate—obesity	0.000128	0.000508	CcSEcCtD
Epirubicin—Confusional state—Sibutramine—obesity	0.000127	0.000507	CcSEcCtD
Epirubicin—Vision blurred—Bupropion—obesity	0.000127	0.000506	CcSEcCtD
Epirubicin—Skin disorder—Orlistat—obesity	0.000127	0.000505	CcSEcCtD
Epirubicin—Gastritis—Topiramate—obesity	0.000126	0.000503	CcSEcCtD
Epirubicin—Oedema—Sibutramine—obesity	0.000126	0.000503	CcSEcCtD
Epirubicin—Anaphylactic shock—Sibutramine—obesity	0.000126	0.000503	CcSEcCtD
Epirubicin—Hyperhidrosis—Orlistat—obesity	0.000126	0.000502	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Topiramate—obesity	0.000126	0.000501	CcSEcCtD
Epirubicin—Muscular weakness—Topiramate—obesity	0.000126	0.000501	CcSEcCtD
Epirubicin—Infection—Sibutramine—obesity	0.000125	0.0005	CcSEcCtD
Epirubicin—Ill-defined disorder—Bupropion—obesity	0.000125	0.000498	CcSEcCtD
Epirubicin—Anaemia—Bupropion—obesity	0.000125	0.000496	CcSEcCtD
Epirubicin—Shock—Sibutramine—obesity	0.000124	0.000495	CcSEcCtD
Epirubicin—Abdominal distension—Topiramate—obesity	0.000124	0.000494	CcSEcCtD
Epirubicin—Agitation—Bupropion—obesity	0.000124	0.000494	CcSEcCtD
Epirubicin—Thrombocytopenia—Sibutramine—obesity	0.000124	0.000492	CcSEcCtD
Epirubicin—Asthma—Topiramate—obesity	0.000123	0.000491	CcSEcCtD
Epirubicin—Dysphagia—Topiramate—obesity	0.000123	0.000491	CcSEcCtD
Epirubicin—Tachycardia—Sibutramine—obesity	0.000123	0.000491	CcSEcCtD
Epirubicin—Skin disorder—Sibutramine—obesity	0.000123	0.000488	CcSEcCtD
Epirubicin—Eosinophilia—Topiramate—obesity	0.000122	0.000486	CcSEcCtD
Epirubicin—Hyperhidrosis—Sibutramine—obesity	0.000122	0.000486	CcSEcCtD
Epirubicin—Malaise—Bupropion—obesity	0.000122	0.000484	CcSEcCtD
Epirubicin—Vertigo—Bupropion—obesity	0.000121	0.000483	CcSEcCtD
Epirubicin—Syncope—Bupropion—obesity	0.000121	0.000482	CcSEcCtD
Epirubicin—Pancreatitis—Topiramate—obesity	0.000121	0.000482	CcSEcCtD
Epirubicin—Leukopenia—Bupropion—obesity	0.000121	0.000481	CcSEcCtD
Epirubicin—Anorexia—Sibutramine—obesity	0.00012	0.000479	CcSEcCtD
Epirubicin—Angina pectoris—Topiramate—obesity	0.00012	0.000478	CcSEcCtD
Epirubicin—Palpitations—Bupropion—obesity	0.000119	0.000475	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Orlistat—obesity	0.000119	0.000473	CcSEcCtD
Epirubicin—Bronchitis—Topiramate—obesity	0.000119	0.000472	CcSEcCtD
Epirubicin—Loss of consciousness—Bupropion—obesity	0.000119	0.000472	CcSEcCtD
Epirubicin—Insomnia—Orlistat—obesity	0.000118	0.00047	CcSEcCtD
Epirubicin—Hypotension—Sibutramine—obesity	0.000118	0.00047	CcSEcCtD
Epirubicin—Cough—Bupropion—obesity	0.000118	0.000469	CcSEcCtD
Epirubicin—Paraesthesia—Orlistat—obesity	0.000117	0.000467	CcSEcCtD
Epirubicin—Pancytopenia—Topiramate—obesity	0.000117	0.000466	CcSEcCtD
Epirubicin—Convulsion—Bupropion—obesity	0.000117	0.000465	CcSEcCtD
Epirubicin—Hypertension—Bupropion—obesity	0.000116	0.000464	CcSEcCtD
Epirubicin—Dysuria—Topiramate—obesity	0.000115	0.000459	CcSEcCtD
Epirubicin—Neutropenia—Topiramate—obesity	0.000115	0.000459	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Sibutramine—obesity	0.000115	0.000458	CcSEcCtD
Epirubicin—Dyspepsia—Orlistat—obesity	0.000115	0.000457	CcSEcCtD
Epirubicin—Chest pain—Bupropion—obesity	0.000115	0.000457	CcSEcCtD
Epirubicin—Myalgia—Bupropion—obesity	0.000115	0.000457	CcSEcCtD
Epirubicin—Arthralgia—Bupropion—obesity	0.000115	0.000457	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Topiramate—obesity	0.000115	0.000456	CcSEcCtD
Epirubicin—Anxiety—Bupropion—obesity	0.000114	0.000456	CcSEcCtD
Epirubicin—Insomnia—Sibutramine—obesity	0.000114	0.000455	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000114	0.000454	CcSEcCtD
Epirubicin—Pollakiuria—Topiramate—obesity	0.000114	0.000454	CcSEcCtD
Epirubicin—Discomfort—Bupropion—obesity	0.000113	0.000452	CcSEcCtD
Epirubicin—Decreased appetite—Orlistat—obesity	0.000113	0.000452	CcSEcCtD
Epirubicin—Paraesthesia—Sibutramine—obesity	0.000113	0.000452	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Orlistat—obesity	0.000113	0.000449	CcSEcCtD
Epirubicin—Dyspnoea—Sibutramine—obesity	0.000113	0.000448	CcSEcCtD
Epirubicin—Photosensitivity reaction—Topiramate—obesity	0.000113	0.000448	CcSEcCtD
Epirubicin—Fatigue—Orlistat—obesity	0.000112	0.000448	CcSEcCtD
Epirubicin—Dry mouth—Bupropion—obesity	0.000112	0.000447	CcSEcCtD
Epirubicin—Somnolence—Sibutramine—obesity	0.000112	0.000447	CcSEcCtD
Epirubicin—Weight increased—Topiramate—obesity	0.000112	0.000447	CcSEcCtD
Epirubicin—Weight decreased—Topiramate—obesity	0.000112	0.000444	CcSEcCtD
Epirubicin—Pain—Orlistat—obesity	0.000112	0.000444	CcSEcCtD
Epirubicin—Hyperglycaemia—Topiramate—obesity	0.000111	0.000443	CcSEcCtD
Epirubicin—Dyspepsia—Sibutramine—obesity	0.000111	0.000443	CcSEcCtD
Epirubicin—Confusional state—Bupropion—obesity	0.000111	0.000442	CcSEcCtD
Epirubicin—Pneumonia—Topiramate—obesity	0.000111	0.00044	CcSEcCtD
Epirubicin—Oedema—Bupropion—obesity	0.00011	0.000438	CcSEcCtD
Epirubicin—Anaphylactic shock—Bupropion—obesity	0.00011	0.000438	CcSEcCtD
Epirubicin—Infestation—Topiramate—obesity	0.00011	0.000438	CcSEcCtD
Epirubicin—Infestation NOS—Topiramate—obesity	0.00011	0.000438	CcSEcCtD
Epirubicin—Decreased appetite—Sibutramine—obesity	0.00011	0.000437	CcSEcCtD
Epirubicin—Infection—Bupropion—obesity	0.000109	0.000436	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Topiramate—obesity	0.000109	0.000434	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Sibutramine—obesity	0.000109	0.000434	CcSEcCtD
Epirubicin—Shock—Bupropion—obesity	0.000108	0.000431	CcSEcCtD
Epirubicin—Renal failure—Topiramate—obesity	0.000108	0.00043	CcSEcCtD
Epirubicin—Pain—Sibutramine—obesity	0.000108	0.00043	CcSEcCtD
Epirubicin—Constipation—Sibutramine—obesity	0.000108	0.00043	CcSEcCtD
Epirubicin—Nervous system disorder—Bupropion—obesity	0.000108	0.00043	CcSEcCtD
Epirubicin—Neuropathy peripheral—Topiramate—obesity	0.000108	0.000429	CcSEcCtD
Epirubicin—Thrombocytopenia—Bupropion—obesity	0.000108	0.000429	CcSEcCtD
Epirubicin—Feeling abnormal—Orlistat—obesity	0.000108	0.000428	CcSEcCtD
Epirubicin—Tachycardia—Bupropion—obesity	0.000107	0.000428	CcSEcCtD
Epirubicin—Stomatitis—Topiramate—obesity	0.000107	0.000427	CcSEcCtD
Epirubicin—Skin disorder—Bupropion—obesity	0.000107	0.000426	CcSEcCtD
Epirubicin—Urinary tract infection—Topiramate—obesity	0.000107	0.000426	CcSEcCtD
Epirubicin—Conjunctivitis—Topiramate—obesity	0.000107	0.000426	CcSEcCtD
Epirubicin—Gastrointestinal pain—Orlistat—obesity	0.000107	0.000425	CcSEcCtD
Epirubicin—Hyperhidrosis—Bupropion—obesity	0.000106	0.000424	CcSEcCtD
Epirubicin—Anorexia—Bupropion—obesity	0.000105	0.000418	CcSEcCtD
Epirubicin—Haematuria—Topiramate—obesity	0.000105	0.000418	CcSEcCtD
Epirubicin—Feeling abnormal—Sibutramine—obesity	0.000104	0.000414	CcSEcCtD
Epirubicin—Epistaxis—Topiramate—obesity	0.000104	0.000413	CcSEcCtD
Epirubicin—Urticaria—Orlistat—obesity	0.000104	0.000413	CcSEcCtD
Epirubicin—Gastrointestinal pain—Sibutramine—obesity	0.000103	0.000411	CcSEcCtD
Epirubicin—Sinusitis—Topiramate—obesity	0.000103	0.000411	CcSEcCtD
Epirubicin—Body temperature increased—Orlistat—obesity	0.000103	0.000411	CcSEcCtD
Epirubicin—Abdominal pain—Orlistat—obesity	0.000103	0.000411	CcSEcCtD
Epirubicin—Hypotension—Bupropion—obesity	0.000103	0.00041	CcSEcCtD
Epirubicin—Agranulocytosis—Topiramate—obesity	0.000103	0.000409	CcSEcCtD
Epirubicin—Bradycardia—Topiramate—obesity	0.0001	0.0004	CcSEcCtD
Epirubicin—Urticaria—Sibutramine—obesity	0.0001	0.000399	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Bupropion—obesity	0.0001	0.000399	CcSEcCtD
Epirubicin—Abdominal pain—Sibutramine—obesity	9.98e-05	0.000398	CcSEcCtD
Epirubicin—Body temperature increased—Sibutramine—obesity	9.98e-05	0.000398	CcSEcCtD
Epirubicin—Insomnia—Bupropion—obesity	9.95e-05	0.000396	CcSEcCtD
Epirubicin—Haemoglobin—Topiramate—obesity	9.92e-05	0.000395	CcSEcCtD
Epirubicin—Rhinitis—Topiramate—obesity	9.9e-05	0.000394	CcSEcCtD
Epirubicin—Paraesthesia—Bupropion—obesity	9.88e-05	0.000394	CcSEcCtD
Epirubicin—Haemorrhage—Topiramate—obesity	9.87e-05	0.000393	CcSEcCtD
Epirubicin—Hepatitis—Topiramate—obesity	9.87e-05	0.000393	CcSEcCtD
Epirubicin—Hypoaesthesia—Topiramate—obesity	9.82e-05	0.000391	CcSEcCtD
Epirubicin—Dyspnoea—Bupropion—obesity	9.81e-05	0.000391	CcSEcCtD
Epirubicin—Pharyngitis—Topiramate—obesity	9.8e-05	0.00039	CcSEcCtD
Epirubicin—Somnolence—Bupropion—obesity	9.78e-05	0.00039	CcSEcCtD
Epirubicin—Urinary tract disorder—Topiramate—obesity	9.75e-05	0.000388	CcSEcCtD
Epirubicin—Oedema peripheral—Topiramate—obesity	9.72e-05	0.000387	CcSEcCtD
Epirubicin—Connective tissue disorder—Topiramate—obesity	9.7e-05	0.000386	CcSEcCtD
Epirubicin—Dyspepsia—Bupropion—obesity	9.69e-05	0.000386	CcSEcCtD
Epirubicin—Urethral disorder—Topiramate—obesity	9.68e-05	0.000385	CcSEcCtD
Epirubicin—Hypersensitivity—Orlistat—obesity	9.61e-05	0.000383	CcSEcCtD
Epirubicin—Decreased appetite—Bupropion—obesity	9.57e-05	0.000381	CcSEcCtD
Epirubicin—Visual impairment—Topiramate—obesity	9.51e-05	0.000379	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Bupropion—obesity	9.5e-05	0.000378	CcSEcCtD
Epirubicin—Fatigue—Bupropion—obesity	9.49e-05	0.000378	CcSEcCtD
Epirubicin—Pain—Bupropion—obesity	9.41e-05	0.000375	CcSEcCtD
Epirubicin—Constipation—Bupropion—obesity	9.41e-05	0.000375	CcSEcCtD
Epirubicin—Asthenia—Orlistat—obesity	9.36e-05	0.000373	CcSEcCtD
Epirubicin—Erythema multiforme—Topiramate—obesity	9.33e-05	0.000372	CcSEcCtD
Epirubicin—Hypersensitivity—Sibutramine—obesity	9.3e-05	0.00037	CcSEcCtD
Epirubicin—Pruritus—Orlistat—obesity	9.23e-05	0.000368	CcSEcCtD
Epirubicin—Eye disorder—Topiramate—obesity	9.22e-05	0.000367	CcSEcCtD
Epirubicin—Tinnitus—Topiramate—obesity	9.2e-05	0.000367	CcSEcCtD
Epirubicin—Cardiac disorder—Topiramate—obesity	9.16e-05	0.000365	CcSEcCtD
Epirubicin—Flushing—Topiramate—obesity	9.16e-05	0.000365	CcSEcCtD
Epirubicin—Feeling abnormal—Bupropion—obesity	9.07e-05	0.000361	CcSEcCtD
Epirubicin—Asthenia—Sibutramine—obesity	9.06e-05	0.000361	CcSEcCtD
Epirubicin—Gastrointestinal pain—Bupropion—obesity	9e-05	0.000358	CcSEcCtD
Epirubicin—Angiopathy—Topiramate—obesity	8.95e-05	0.000357	CcSEcCtD
Epirubicin—Pruritus—Sibutramine—obesity	8.93e-05	0.000356	CcSEcCtD
Epirubicin—Diarrhoea—Orlistat—obesity	8.93e-05	0.000355	CcSEcCtD
Epirubicin—Immune system disorder—Topiramate—obesity	8.92e-05	0.000355	CcSEcCtD
Epirubicin—Mediastinal disorder—Topiramate—obesity	8.9e-05	0.000354	CcSEcCtD
Epirubicin—Chills—Topiramate—obesity	8.86e-05	0.000353	CcSEcCtD
Epirubicin—Urticaria—Bupropion—obesity	8.74e-05	0.000348	CcSEcCtD
Epirubicin—Alopecia—Topiramate—obesity	8.72e-05	0.000347	CcSEcCtD
Epirubicin—Body temperature increased—Bupropion—obesity	8.7e-05	0.000347	CcSEcCtD
Epirubicin—Abdominal pain—Bupropion—obesity	8.7e-05	0.000347	CcSEcCtD
Epirubicin—Mental disorder—Topiramate—obesity	8.65e-05	0.000344	CcSEcCtD
Epirubicin—Diarrhoea—Sibutramine—obesity	8.64e-05	0.000344	CcSEcCtD
Epirubicin—Dizziness—Orlistat—obesity	8.63e-05	0.000344	CcSEcCtD
Epirubicin—Malnutrition—Topiramate—obesity	8.59e-05	0.000342	CcSEcCtD
Epirubicin—Erythema—Topiramate—obesity	8.59e-05	0.000342	CcSEcCtD
Epirubicin—Flatulence—Topiramate—obesity	8.47e-05	0.000337	CcSEcCtD
Epirubicin—Tension—Topiramate—obesity	8.43e-05	0.000336	CcSEcCtD
Epirubicin—Dysgeusia—Topiramate—obesity	8.41e-05	0.000335	CcSEcCtD
Epirubicin—Dizziness—Sibutramine—obesity	8.35e-05	0.000333	CcSEcCtD
Epirubicin—Nervousness—Topiramate—obesity	8.34e-05	0.000332	CcSEcCtD
Epirubicin—Back pain—Topiramate—obesity	8.31e-05	0.000331	CcSEcCtD
Epirubicin—Vomiting—Orlistat—obesity	8.29e-05	0.00033	CcSEcCtD
Epirubicin—Muscle spasms—Topiramate—obesity	8.26e-05	0.000329	CcSEcCtD
Epirubicin—Rash—Orlistat—obesity	8.23e-05	0.000328	CcSEcCtD
Epirubicin—Dermatitis—Orlistat—obesity	8.22e-05	0.000327	CcSEcCtD
Epirubicin—Headache—Orlistat—obesity	8.17e-05	0.000325	CcSEcCtD
Epirubicin—Hypersensitivity—Bupropion—obesity	8.11e-05	0.000323	CcSEcCtD
Epirubicin—Vision blurred—Topiramate—obesity	8.1e-05	0.000323	CcSEcCtD
Epirubicin—Vomiting—Sibutramine—obesity	8.03e-05	0.00032	CcSEcCtD
Epirubicin—Ill-defined disorder—Topiramate—obesity	7.97e-05	0.000318	CcSEcCtD
Epirubicin—Rash—Sibutramine—obesity	7.96e-05	0.000317	CcSEcCtD
Epirubicin—Dermatitis—Sibutramine—obesity	7.95e-05	0.000317	CcSEcCtD
Epirubicin—Anaemia—Topiramate—obesity	7.94e-05	0.000316	CcSEcCtD
Epirubicin—Headache—Sibutramine—obesity	7.91e-05	0.000315	CcSEcCtD
Epirubicin—Asthenia—Bupropion—obesity	7.9e-05	0.000315	CcSEcCtD
Epirubicin—Agitation—Topiramate—obesity	7.9e-05	0.000314	CcSEcCtD
Epirubicin—Pruritus—Bupropion—obesity	7.79e-05	0.00031	CcSEcCtD
Epirubicin—Nausea—Orlistat—obesity	7.75e-05	0.000309	CcSEcCtD
Epirubicin—Malaise—Topiramate—obesity	7.75e-05	0.000309	CcSEcCtD
Epirubicin—Vertigo—Topiramate—obesity	7.72e-05	0.000307	CcSEcCtD
Epirubicin—Syncope—Topiramate—obesity	7.71e-05	0.000307	CcSEcCtD
Epirubicin—Leukopenia—Topiramate—obesity	7.69e-05	0.000306	CcSEcCtD
Epirubicin—Palpitations—Topiramate—obesity	7.59e-05	0.000302	CcSEcCtD
Epirubicin—Loss of consciousness—Topiramate—obesity	7.55e-05	0.000301	CcSEcCtD
Epirubicin—Diarrhoea—Bupropion—obesity	7.53e-05	0.0003	CcSEcCtD
Epirubicin—Nausea—Sibutramine—obesity	7.5e-05	0.000299	CcSEcCtD
Epirubicin—Cough—Topiramate—obesity	7.5e-05	0.000299	CcSEcCtD
Epirubicin—Convulsion—Topiramate—obesity	7.44e-05	0.000296	CcSEcCtD
Epirubicin—Hypertension—Topiramate—obesity	7.42e-05	0.000295	CcSEcCtD
Epirubicin—Arthralgia—Topiramate—obesity	7.31e-05	0.000291	CcSEcCtD
Epirubicin—Chest pain—Topiramate—obesity	7.31e-05	0.000291	CcSEcCtD
Epirubicin—Myalgia—Topiramate—obesity	7.31e-05	0.000291	CcSEcCtD
Epirubicin—Anxiety—Topiramate—obesity	7.29e-05	0.00029	CcSEcCtD
Epirubicin—Dizziness—Bupropion—obesity	7.28e-05	0.00029	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	7.26e-05	0.000289	CcSEcCtD
Epirubicin—Discomfort—Topiramate—obesity	7.23e-05	0.000288	CcSEcCtD
Epirubicin—Dry mouth—Topiramate—obesity	7.15e-05	0.000285	CcSEcCtD
Epirubicin—Confusional state—Topiramate—obesity	7.07e-05	0.000282	CcSEcCtD
Epirubicin—Oedema—Topiramate—obesity	7.01e-05	0.000279	CcSEcCtD
Epirubicin—Vomiting—Bupropion—obesity	7e-05	0.000279	CcSEcCtD
Epirubicin—Infection—Topiramate—obesity	6.97e-05	0.000277	CcSEcCtD
Epirubicin—Rash—Bupropion—obesity	6.94e-05	0.000276	CcSEcCtD
Epirubicin—Dermatitis—Bupropion—obesity	6.93e-05	0.000276	CcSEcCtD
Epirubicin—Shock—Topiramate—obesity	6.9e-05	0.000275	CcSEcCtD
Epirubicin—Headache—Bupropion—obesity	6.9e-05	0.000275	CcSEcCtD
Epirubicin—Nervous system disorder—Topiramate—obesity	6.88e-05	0.000274	CcSEcCtD
Epirubicin—Thrombocytopenia—Topiramate—obesity	6.87e-05	0.000273	CcSEcCtD
Epirubicin—Tachycardia—Topiramate—obesity	6.84e-05	0.000273	CcSEcCtD
Epirubicin—Skin disorder—Topiramate—obesity	6.81e-05	0.000271	CcSEcCtD
Epirubicin—Hyperhidrosis—Topiramate—obesity	6.78e-05	0.00027	CcSEcCtD
Epirubicin—Anorexia—Topiramate—obesity	6.68e-05	0.000266	CcSEcCtD
Epirubicin—Hypotension—Topiramate—obesity	6.55e-05	0.000261	CcSEcCtD
Epirubicin—Nausea—Bupropion—obesity	6.54e-05	0.00026	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Topiramate—obesity	6.39e-05	0.000254	CcSEcCtD
Epirubicin—Insomnia—Topiramate—obesity	6.34e-05	0.000253	CcSEcCtD
Epirubicin—Paraesthesia—Topiramate—obesity	6.3e-05	0.000251	CcSEcCtD
Epirubicin—Dyspnoea—Topiramate—obesity	6.25e-05	0.000249	CcSEcCtD
Epirubicin—Somnolence—Topiramate—obesity	6.23e-05	0.000248	CcSEcCtD
Epirubicin—Dyspepsia—Topiramate—obesity	6.17e-05	0.000246	CcSEcCtD
Epirubicin—Decreased appetite—Topiramate—obesity	6.1e-05	0.000243	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Topiramate—obesity	6.05e-05	0.000241	CcSEcCtD
Epirubicin—Fatigue—Topiramate—obesity	6.05e-05	0.000241	CcSEcCtD
Epirubicin—Pain—Topiramate—obesity	6e-05	0.000239	CcSEcCtD
Epirubicin—Constipation—Topiramate—obesity	6e-05	0.000239	CcSEcCtD
Epirubicin—Feeling abnormal—Topiramate—obesity	5.78e-05	0.00023	CcSEcCtD
Epirubicin—Gastrointestinal pain—Topiramate—obesity	5.73e-05	0.000228	CcSEcCtD
Epirubicin—Urticaria—Topiramate—obesity	5.57e-05	0.000222	CcSEcCtD
Epirubicin—Abdominal pain—Topiramate—obesity	5.54e-05	0.000221	CcSEcCtD
Epirubicin—Body temperature increased—Topiramate—obesity	5.54e-05	0.000221	CcSEcCtD
Epirubicin—Hypersensitivity—Topiramate—obesity	5.17e-05	0.000206	CcSEcCtD
Epirubicin—Asthenia—Topiramate—obesity	5.03e-05	0.0002	CcSEcCtD
Epirubicin—Pruritus—Topiramate—obesity	4.96e-05	0.000198	CcSEcCtD
Epirubicin—Diarrhoea—Topiramate—obesity	4.8e-05	0.000191	CcSEcCtD
Epirubicin—Dizziness—Topiramate—obesity	4.64e-05	0.000185	CcSEcCtD
Epirubicin—Vomiting—Topiramate—obesity	4.46e-05	0.000178	CcSEcCtD
Epirubicin—Rash—Topiramate—obesity	4.42e-05	0.000176	CcSEcCtD
Epirubicin—Dermatitis—Topiramate—obesity	4.42e-05	0.000176	CcSEcCtD
Epirubicin—Headache—Topiramate—obesity	4.39e-05	0.000175	CcSEcCtD
Epirubicin—Nausea—Topiramate—obesity	4.17e-05	0.000166	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.47e-05	8.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOC3—obesity	1.46e-05	8.7e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC2A4—obesity	1.46e-05	8.69e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GCG—obesity	1.46e-05	8.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—obesity	1.45e-05	8.64e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.45e-05	8.62e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKR1C3—obesity	1.45e-05	8.6e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYCS—obesity	1.44e-05	8.58e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HTR2A—obesity	1.44e-05	8.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—C3—obesity	1.43e-05	8.52e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GCG—obesity	1.43e-05	8.52e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC2A4—obesity	1.43e-05	8.52e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CETP—obesity	1.42e-05	8.45e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GGT1—obesity	1.42e-05	8.42e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GOT1—obesity	1.42e-05	8.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYCS—obesity	1.42e-05	8.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NPS—obesity	1.41e-05	8.38e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—obesity	1.41e-05	8.37e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS1—obesity	1.41e-05	8.36e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SDC1—obesity	1.41e-05	8.35e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NCOA1—obesity	1.4e-05	8.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TCF7L2—obesity	1.39e-05	8.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GGT1—obesity	1.39e-05	8.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GOT1—obesity	1.39e-05	8.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR2C—obesity	1.38e-05	8.22e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DRD1—obesity	1.38e-05	8.22e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKR1C3—obesity	1.38e-05	8.22e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP19A1—obesity	1.38e-05	8.17e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—STK11—obesity	1.38e-05	8.17e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC2A4—obesity	1.37e-05	8.13e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NCOA1—obesity	1.37e-05	8.13e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGT—obesity	1.36e-05	8.1e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SCARB1—obesity	1.36e-05	8.09e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—STK11—obesity	1.35e-05	8.01e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP19A1—obesity	1.35e-05	8.01e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK2—obesity	1.35e-05	8e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.34e-05	7.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB1—obesity	1.34e-05	7.96e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—obesity	1.33e-05	7.88e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GOT1—obesity	1.33e-05	7.87e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SREBF1—obesity	1.32e-05	7.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PARP1—obesity	1.31e-05	7.79e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GHRL—obesity	1.31e-05	7.79e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRL—obesity	1.31e-05	7.76e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DRD4—obesity	1.3e-05	7.73e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GOT2—obesity	1.29e-05	7.64e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—COMT—obesity	1.28e-05	7.6e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.27e-05	7.53e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARGC1A—obesity	1.26e-05	7.49e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNB3—obesity	1.26e-05	7.49e-05	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—obesity	1.26e-05	7.49e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCB—obesity	1.26e-05	7.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—F2—obesity	1.26e-05	7.48e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—obesity	1.26e-05	7.48e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—FASN—obesity	1.26e-05	7.48e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—obesity	1.25e-05	7.46e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—COMT—obesity	1.25e-05	7.45e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—BCHE—obesity	1.25e-05	7.45e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CNR1—obesity	1.24e-05	7.38e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FOXO3—obesity	1.24e-05	7.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARGC1A—obesity	1.24e-05	7.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNB3—obesity	1.24e-05	7.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—obesity	1.23e-05	7.31e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNAS—obesity	1.23e-05	7.29e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TCF7L2—obesity	1.22e-05	7.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DRD2—obesity	1.21e-05	7.2e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2E1—obesity	1.21e-05	7.18e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CG—obesity	1.21e-05	7.16e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNAS—obesity	1.2e-05	7.15e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOB—obesity	1.2e-05	7.14e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTPN1—obesity	1.2e-05	7.13e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GCG—obesity	1.2e-05	7.13e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NQO1—obesity	1.2e-05	7.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOB—obesity	1.18e-05	7e-05	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—obesity	1.17e-05	6.98e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.17e-05	6.95e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.16e-05	6.89e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—obesity	1.15e-05	6.85e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LPL—obesity	1.15e-05	6.82e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—obesity	1.15e-05	6.82e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GCG—obesity	1.15e-05	6.81e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC2A4—obesity	1.15e-05	6.81e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRL—obesity	1.14e-05	6.8e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYCS—obesity	1.13e-05	6.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STK11—obesity	1.13e-05	6.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LPL—obesity	1.13e-05	6.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOB—obesity	1.12e-05	6.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL2—obesity	1.12e-05	6.67e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPX1—obesity	1.12e-05	6.65e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLG—obesity	1.12e-05	6.62e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GGT1—obesity	1.11e-05	6.59e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GOT1—obesity	1.11e-05	6.59e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT2—obesity	1.1e-05	6.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPX1—obesity	1.1e-05	6.52e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NCOA1—obesity	1.09e-05	6.5e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CD36—obesity	1.09e-05	6.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FOXO3—obesity	1.09e-05	6.47e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB2—obesity	1.09e-05	6.45e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP19A1—obesity	1.08e-05	6.4e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—STK11—obesity	1.08e-05	6.4e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LPL—obesity	1.07e-05	6.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CD36—obesity	1.07e-05	6.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SOCS1—obesity	1.07e-05	6.35e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FOXO1—obesity	1.07e-05	6.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CD—obesity	1.06e-05	6.29e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SOCS3—obesity	1.06e-05	6.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNB3—obesity	1.03e-05	6.14e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—obesity	1.03e-05	6.14e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TYK2—obesity	1.02e-05	6.06e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF2—obesity	1.02e-05	6.03e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARA—obesity	1.01e-05	6.02e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—obesity	1.01e-05	6.02e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RHOA—obesity	1.01e-05	6.01e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNAS—obesity	1.01e-05	5.98e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—COMT—obesity	1e-05	5.95e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3R1—obesity	1e-05	5.94e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARA—obesity	9.94e-06	5.91e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKCD—obesity	9.89e-06	5.88e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNB3—obesity	9.88e-06	5.87e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARGC1A—obesity	9.88e-06	5.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOB—obesity	9.86e-06	5.86e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—obesity	9.83e-06	5.84e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AGT—obesity	9.82e-06	5.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—obesity	9.81e-06	5.83e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—obesity	9.67e-06	5.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AGT—obesity	9.63e-06	5.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL5—obesity	9.63e-06	5.72e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOE—obesity	9.62e-06	5.72e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNAS—obesity	9.62e-06	5.71e-05	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—obesity	9.6e-06	5.7e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAV1—obesity	9.53e-06	5.66e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOA1—obesity	9.51e-06	5.65e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOE—obesity	9.43e-06	5.61e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOB—obesity	9.42e-06	5.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LPL—obesity	9.41e-06	5.59e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAV1—obesity	9.35e-06	5.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FOXO1—obesity	9.34e-06	5.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RPS6KB1—obesity	9.33e-06	5.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOA1—obesity	9.33e-06	5.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CB—obesity	9.24e-06	5.49e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS2—obesity	9.2e-06	5.46e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOE—obesity	9e-06	5.35e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LPL—obesity	8.99e-06	5.34e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—obesity	8.93e-06	5.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CAV1—obesity	8.92e-06	5.3e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOA1—obesity	8.9e-06	5.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPX1—obesity	8.77e-06	5.21e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CG—obesity	8.68e-06	5.16e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCD—obesity	8.67e-06	5.15e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CD36—obesity	8.54e-06	5.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CG—obesity	8.51e-06	5.06e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR2A—obesity	8.49e-06	5.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C3—obesity	8.47e-06	5.03e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BAD—obesity	8.39e-06	4.98e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—obesity	8.38e-06	4.98e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—POMC—obesity	8.26e-06	4.91e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—INS—obesity	8.22e-06	4.88e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—obesity	8.22e-06	4.88e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—obesity	8.1e-06	4.82e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—obesity	8.1e-06	4.81e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS2—obesity	8.06e-06	4.79e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—INS—obesity	8.06e-06	4.79e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGT—obesity	8.05e-06	4.78e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS1—obesity	8.03e-06	4.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—obesity	8.01e-06	4.76e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARA—obesity	7.94e-06	4.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—obesity	7.89e-06	4.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOE—obesity	7.89e-06	4.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CAV1—obesity	7.82e-06	4.64e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOA1—obesity	7.8e-06	4.63e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AGT—obesity	7.69e-06	4.57e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—INS—obesity	7.69e-06	4.57e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CD—obesity	7.63e-06	4.53e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOE—obesity	7.54e-06	4.48e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—obesity	7.53e-06	4.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ESR1—obesity	7.53e-06	4.47e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CD—obesity	7.49e-06	4.45e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAV1—obesity	7.47e-06	4.44e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOA1—obesity	7.45e-06	4.43e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCB—obesity	7.44e-06	4.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2—obesity	7.44e-06	4.42e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT2—obesity	7.43e-06	4.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—obesity	7.39e-06	4.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BAD—obesity	7.35e-06	4.37e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—obesity	7.21e-06	4.28e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3R1—obesity	7.21e-06	4.28e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CD—obesity	7.14e-06	4.24e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.14e-06	4.24e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CG—obesity	7.12e-06	4.23e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—obesity	7.07e-06	4.2e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3R1—obesity	7.07e-06	4.2e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—obesity	7.06e-06	4.2e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS1—obesity	7.04e-06	4.18e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TYK2—obesity	6.87e-06	4.08e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RHOA—obesity	6.81e-06	4.05e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CG—obesity	6.8e-06	4.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—obesity	6.78e-06	4.03e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3R1—obesity	6.74e-06	4.01e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—obesity	6.74e-06	4.01e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—INS—obesity	6.74e-06	4e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CB—obesity	6.65e-06	3.95e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL2—obesity	6.63e-06	3.94e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—obesity	6.59e-06	3.92e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—obesity	6.57e-06	3.9e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CB—obesity	6.52e-06	3.88e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1—obesity	6.52e-06	3.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT2—obesity	6.51e-06	3.87e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—obesity	6.48e-06	3.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—obesity	6.46e-06	3.84e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—INS—obesity	6.44e-06	3.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CD—obesity	6.26e-06	3.72e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CB—obesity	6.22e-06	3.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTOR—obesity	6.22e-06	3.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—obesity	6.19e-06	3.68e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—obesity	6.17e-06	3.66e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TYK2—obesity	6.02e-06	3.58e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CD—obesity	5.98e-06	3.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RHOA—obesity	5.97e-06	3.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—obesity	5.91e-06	3.51e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3R1—obesity	5.91e-06	3.51e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—obesity	5.9e-06	3.51e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3R1—obesity	5.65e-06	3.36e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—obesity	5.65e-06	3.36e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—obesity	5.63e-06	3.34e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MTOR—obesity	5.46e-06	3.24e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CB—obesity	5.46e-06	3.24e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CB—obesity	5.21e-06	3.1e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—obesity	5.17e-06	3.07e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—obesity	4.99e-06	2.96e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—obesity	4.81e-06	2.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—obesity	4.74e-06	2.82e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK8—obesity	4.61e-06	2.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—obesity	4.6e-06	2.73e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—obesity	4.47e-06	2.66e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—obesity	4.46e-06	2.65e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—obesity	4.22e-06	2.5e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—obesity	4.06e-06	2.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—obesity	3.98e-06	2.36e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—obesity	3.92e-06	2.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—obesity	3.91e-06	2.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—obesity	3.79e-06	2.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—obesity	3.36e-06	2e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—obesity	3.33e-06	1.98e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—obesity	3.31e-06	1.97e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—obesity	3.25e-06	1.93e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—obesity	3.18e-06	1.89e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—obesity	3.1e-06	1.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—obesity	2.94e-06	1.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—obesity	2.72e-06	1.61e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—obesity	2.6e-06	1.54e-05	CbGpPWpGaD
